Hemofarm Group je zdravju zavezana mednarodna farmacevtska skupina, ki z proizvodnjo visoko kakovostnih zdravil ljudem omogoča boljšo kvaliteto življenja. Z uspešnim poslovanjem prispeva k blaginji svojih delničarjev, zaposlenih in širše skupnosti z ustvarjanjem bolj zdravega delovnega in življenjskega okolja.

Več o Hemofarm

Vjera Pejanović, Director of the Hemofarm Institute

"We have seen how the system works in other pharmaceutical companies with which we will share information in the future about future advanced solutions.”

There are several reasons why Hemofarm management opted for the GLORYA project. The most important ones are definitely providing the appropriate response to strict international regulatory demands and achieving greater competitiveness on foreign markets. The pharmaceutical industry is the type of the industry where success, in comparison with other competitive companies, largely depends on the time needed to introduce a new product on the market. At the same time, this branch of industry is burdened with producing a lot of documentation, which, as experience shows, represents one of the major obstacles to the timely introduction of a product to the market. So, every procedure that increases the speed at which the process of preparing the documentation is carried out has a major influence on the overall success of the company. 

The decision by the Hemofarm management is in line with the trends prevalent on the global market; according to analyses by experts at Gartner, documentation and process management are at the top of the Information Technology and project investment list.